• In recent weeks, IPG Photonics has been at the center of several developments, including PPG Industries’ and Whirlpool’s collaboration to commercialize its PhotoniCURE laser curing systems for powder coatings, a roughly US$10,000,000 CROSSBOW high-energy laser counter‑UAS order from Lockheed Martin, and an adverse but limited patent ruling in Europe affecting a small portion of its AMB laser products.
• Together, these events highlight how IPG Photonics is pushing its laser technology into new industrial and defense uses while simultaneously managing legal risks that currently touch less than 1% of its total sales.
• We’ll now consider how the PPG–Whirlpool laser curing collaboration, alongside the new defense order, reshapes IPG Photonics’ existing investment narrative.

Find 48 companies with promising cash flow potential yet trading below their fair value.

IPG Photonics Investment Narrative Recap

To own IPG Photonics, you really need to believe that its core industrial laser business can steadily recover while newer applications in areas like coatings and defense grow into meaningful profit drivers. The recent PPG–Whirlpool PhotoniCURE collaboration and the US$10,000,000 CROSSBOW counter‑UAS order both support that “advanced applications” story, while the European AMB patent ruling, although currently affecting less than 1% of sales, underlines that legal and competitive risks are very real.

Among the recent announcements, the PPG and Whirlpool collaboration looks especially important because it puts IPG’s PhotoniCURE technology directly inside a large customer’s production trials. For investors focused on near term catalysts, this is a concrete example of IPG trying to turn its coatings partnerships into broader, repeatable industrial demand, which could help offset any ongoing softness in traditional cutting and welding applications if adoption progresses well.

Yet against this positive backdrop, the legal overhang from the AMB patent dispute is something investors should be aware of, because it could still...

IPG Photonics’ narrative projects $1.2 billion revenue and $133.9 million earnings by 2028. This implies an earnings increase from today’s level to reach the forecast consensus by that year.

Uncover how IPG Photonics' forecasts yield a $96.08 fair value, a 18% downside to its current price.

Exploring Other Perspectives

The most optimistic analysts were already assuming revenue of about US$1.2 billion and earnings near US$169 million by 2028, so when you weigh that against early CROSSBOW traction in defense, it shows how far opinions can differ and why it is worth comparing multiple views rather than relying on a single earnings path.

Explore 2 other fair value estimates on IPG Photonics - why the stock might be worth as much as 11% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your IPG Photonics research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free IPG Photonics research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate IPG Photonics' overall financial health at a glance.

Interested In Other Possibilities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Invest in the nuclear renaissance through our list of 86 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.